Vital Therapies (VTL) Reaches $3.20 After 8.00% Up Move; Coho Partners LTD Has Decreased Praxair (PX) Position

September 5, 2017 - By Kurt Siggers

The stock of Vital Therapies Inc (NASDAQ:VTL) is a huge mover today! About 105,752 shares traded or 0.38% up from the average. Vital Therapies Inc (NASDAQ:VTL) has declined 61.75% since September 5, 2016 and is downtrending. It has underperformed by 78.45% the S&P500.The move comes after 7 months positive chart setup for the $135.06M company. It was reported on Sep, 5 by Barchart.com. We have $3.46 PT which if reached, will make NASDAQ:VTL worth $10.80M more.

Coho Partners Ltd decreased Praxair Inc. (PX) stake by 87.24% reported in 2016Q4 SEC filing. Coho Partners Ltd sold 12,022 shares as Praxair Inc. (PX)’s stock rose 10.06%. The Coho Partners Ltd holds 1,759 shares with $206,000 value, down from 13,781 last quarter. Praxair Inc. now has $37.25B valuation. The stock declined 0.60% or $0.79 reaching $130.24 per share. About 522,863 shares traded. Praxair, Inc. (NYSE:PX) has risen 17.42% since September 5, 2016 and is uptrending. It has outperformed by 0.72% the S&P500.

Among 20 analysts covering Praxair (NYSE:PX), 6 have Buy rating, 3 Sell and 11 Hold. Therefore 30% are positive. Praxair had 33 analyst reports since August 12, 2015 according to SRatingsIntel. Deutsche Bank downgraded it to “Hold” rating and $120 target in Monday, April 4 report. The firm has “Buy” rating by Bank of America given on Wednesday, June 7. As per Wednesday, June 21, the company rating was maintained by Jefferies. The company was upgraded on Friday, January 27 by JP Morgan. The company was upgraded on Wednesday, January 13 by Seaport Global Securities. Deutsche Bank maintained Praxair, Inc. (NYSE:PX) rating on Friday, June 2. Deutsche Bank has “Hold” rating and $13000 target. As per Tuesday, September 13, the company rating was initiated by Morgan Stanley. UBS maintained Praxair, Inc. (NYSE:PX) rating on Wednesday, November 18. UBS has “Neutral” rating and $113 target. The stock of Praxair, Inc. (NYSE:PX) has “Equal Weight” rating given on Monday, May 2 by Barclays Capital. The rating was upgraded by Zacks on Friday, August 28 to “Sell”.

Investors sentiment decreased to 0.9 in Q4 2016. Its down 0.14, from 1.04 in 2016Q3. It turned negative, as 44 investors sold PX shares while 290 reduced holdings. 79 funds opened positions while 261 raised stakes. 231.14 million shares or 1.70% more from 227.29 million shares in 2016Q3 were reported. Seaward Mgmt Lp invested 0.45% of its portfolio in Praxair, Inc. (NYSE:PX). Sumitomo Mitsui Asset invested in 21,669 shares. Fayez Sarofim & has invested 0.86% of its portfolio in Praxair, Inc. (NYSE:PX). Connors Investor Services holds 1.23% or 61,628 shares. Somerset Communication holds 0.68% in Praxair, Inc. (NYSE:PX) or 9,723 shares. Mawer Invest Mgmt Limited holds 842,246 shares. Dnb Asset Mgmt As invested in 0% or 28,003 shares. Virginia Retirement Et Al accumulated 18,900 shares or 0.03% of the stock. Blackrock Fund Advsrs owns 0.09% invested in Praxair, Inc. (NYSE:PX) for 4.26 million shares. First Allied Advisory Svcs reported 0.02% of its portfolio in Praxair, Inc. (NYSE:PX). Nottingham Advsrs accumulated 0.04% or 1,981 shares. Bb&T Corp has invested 0.02% in Praxair, Inc. (NYSE:PX). Legal General Gru Public Ltd Liability invested 0.15% of its portfolio in Praxair, Inc. (NYSE:PX). United Ser Automobile Association accumulated 163,141 shares. Csu Producer Resource accumulated 9,600 shares.

Coho Partners Ltd increased State Street Corp. (NYSE:STT) stake by 7,437 shares to 1.56M valued at $121.43M in 2016Q4. It also upped Automatic Data Processing Inc. (NASDAQ:ADP) stake by 7,749 shares and now owns 1.30M shares. Dollar General (NYSE:DG) was raised too.

Among 7 analysts covering Vital Therapies Inc (NASDAQ:VTL), 3 have Buy rating, 0 Sell and 4 Hold. Therefore 43% are positive. Vital Therapies Inc had 11 analyst reports since August 7, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Monday, August 10 by Credit Suisse. The rating was maintained by Canaccord Genuity on Monday, August 24 with “Buy”. The firm has “Buy” rating by SunTrust given on Monday, August 24. The stock of Vital Therapies Inc (NASDAQ:VTL) has “Buy” rating given on Friday, August 7 by BTIG Research. The firm has “Neutral” rating given on Monday, August 24 by Credit Suisse. On Monday, August 24 the stock rating was downgraded by Suntrust Robinson to “Neutral”. The firm has “Neutral” rating by Suntrust Robinson given on Tuesday, September 29. The stock of Vital Therapies Inc (NASDAQ:VTL) has “Outperform” rating given on Monday, August 24 by William Blair. BTIG Research downgraded the shares of VTL in report on Monday, October 26 to “Neutral” rating. As per Tuesday, September 29, the company rating was downgraded by SunTrust.

Since March 27, 2017, it had 9 insider purchases, and 0 insider sales for $15.32 million activity. On Thursday, June 8 the insider Satter Muneer A bought $93,306. The insider BIENAIME JEAN JACQUES bought 16,000 shares worth $48,069. $30,981 worth of stock was bought by Winters Terence E. on Wednesday, June 14. Nash Duane also bought $12,182 worth of Vital Therapies Inc (NASDAQ:VTL) on Thursday, June 8. $7,724 worth of Vital Therapies Inc (NASDAQ:VTL) was bought by DUNN JOHN MICHAEL. Ashley Robert A. bought $6,360 worth of stock or 2,000 shares.